Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Date: February 1, 2023

Time: 12:00PM - 01:00PM

You must be registered to participate!

Speakers: